Anterolateral Portal Is Less Painful than Superolateral Portal in Knee Intra-Articular Injection
10.5792/ksrr.2015.27.4.228
- Author:
Sung Yup LEE
1
;
Kiran Kumar GN
;
Byung June CHUNG
;
Sang Wook LEE
;
Tae Kyun KIM
Author Information
1. Department of Orthopaedic Surgery, Seoul National University Bundang Hospital, Seongnam, Korea. osktk@snubh.org
- Publication Type:Randomized Controlled Trial
- Keywords:
Knee;
Osteoarthritis;
Intra-articular injection
- MeSH:
Arthritis, Rheumatoid;
Humans;
Hyaluronic Acid;
Injections, Intra-Articular;
Knee Joint;
Knee;
Needles;
Osteoarthritis;
Triamcinolone
- From:The Journal of Korean Knee Society
2015;27(4):228-232
- CountryRepublic of Korea
- Language:English
-
Abstract:
PURPOSE: Intra-articular knee injections are commonly performed in clinical practice for treating various knee joint disorders such as osteoarthritis and rheumatoid arthritis. When selecting the portal for injection, not only intra-articular needle accuracy but also procedural pain should be taken into consideration. The purpose of this study was to determine whether injection through anterolateral portal provokes less pain and provides better pain relief compared to superolateral portal. MATERIALS AND METHODS: A total of 60 patients with primary osteoarthritis of the knee receiving intra-articular injections were randomized into 2 groups according to the type of portal approach; anterolateral or superolateral. All patients received hyaluronic acid (20 mg) and triamcinolone (40 mg) as the first injection followed by second and third injections of hyaluronic acid on a weekly basis. Underlying knee pain, procedural pain, and knee pain at 4 weeks were evaluated using visual analogue scale (VAS). RESULTS: Injection through anterolateral portal provoked less pain (VAS, 1.5+/-1.3) than the superolateral portal (VAS, 1.5 vs. 2.7; p=0.004). No differences were found in the degree of pain relief at weeks between the two groups (p=0.517). CONCLUSIONS: We recommend the use of anterolateral portal for intra-articular knee injection as it provokes less pain and comparably short-term pain relief than the superolateral portal.
